Biotech and BNB treasury firm Windtree Therapeutics fell 77% on Wednesday after informing the SEC that it would be delisted from the Nasdaq stock exchange.
BNB treasury company plunges 77% after Nasdaq delisting notice
Related posts
Crypto groups slam Citadel for urging tighter DeFi tokenization rules
SEC clears DTCC to offer securities market tokenization service
Terraform co-founder sentenced to 15 years in prison after guilty plea
Vote on Trump’s CFTC chair pick could come today, US senator says
Bank of Mexico warns fragmented global rules expose stablecoins to stress, arbitrage
US SEC’s Crenshaw takes aim at crypto in final weeks at the agency
